Filing Flows › Roivant Sciences (ROIV) › Q4 FY26
Roivant Sciences (ROIV) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed May 20, 2026
Roivant Sciences (ROIV) reported revenue of $2.5M for the fourth quarter fiscal 2026 (Q4 FY26), -67% from a year earlier and +26% from the quarter before.
Roivant Sciences, Q4 FY26: revenue $2.5M (-67% year over year), net earnings $303M, operating cash flow −$164M. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | +26% | -67% |
| Operating profit | $415M | — | — |
| Net earnings | $303M | — | — |
| Operating cash flow | −$164M | — | — |
What changed
Revenue was $2.5M in Q4 FY26, down 67% year over year and up 26% from the previous quarter.
Operating profit was $415.2M, a 16477.8% margin (up 20242.2 points year over year). Net earnings were $303.0M. The effective tax rate was 21.7%.
Operating cash flow was −$163.8M. Non-cash charges added back $638K of depreciation and amortization and $77.2M of share-based compensation. Working capital and other items used $597.4M. Capital expenditures of $1.3M exceeded it, leaving free cash flow of −$165.1M.
Questions
What was Roivant Sciences' revenue in the fourth quarter fiscal 2026?
Roivant Sciences (ROIV) reported revenue of $2.5M for the fourth quarter fiscal 2026 (Q4 FY26), -67% from a year earlier and +26% from the quarter before.
Source: Roivant Sciences 10-K on SEC EDGAR.